Abstract
BackgroundSelf-injectable contraceptives, namely subcutaneous depot medroxyprogesterone acetate 104 mg micronised formulation delivered via uniject system, reduce the need to travel to a facility for contraceptive access, but the initial, in-person,...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have